Penny Stock News

Loading...

Monday, March 15, 2010

ADXS Develops New Sorage For Listeria

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)-Advaxis Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company has developing a long-term, room temperature, storage-stable form of its vaccines. This would replace the current requirement to keep the product frozen at -70o C before use.

No comments: